Clinical trial
Simvastatin as a Treatment for Pulmonary Hypertension
NCT00180713 · Imperial College London, Other · Completed
Key facts
| NCT number | NCT00180713 |
|---|---|
| Title | Simvastatin as a Treatment for Pulmonary Hypertension |
| Official title | Simvastatin as a Treatment for Pulmonary Hypertension |
| Lead sponsor | Imperial College London, Other |
| Collaborators | Medical Research Council |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Pulmonary Hypertension |
| Intervention type | Drug |
| Interventions | Simvastatin, Placebo |
| Enrollment | 42 |
| Start date | Oct 1, 2005 |
| Primary completion | Oct 1, 2008 |
| Completion | May 1, 2009 |
| First posted | Sep 16, 2005 |
| Last update posted | Aug 21, 2019 |
| Countries | Germany, United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: